[{"Assets_0_Q3_USD":507298000.0,"CommonStockSharesOutstanding_0_Q3_shares":38119486.0,"EarningsPerShareBasic_3_Q3_USD":0.83,"EarningsPerShareBasic_1_Q3_USD":0.27,"EarningsPerShareDiluted_3_Q3_USD":0.82,"EarningsPerShareDiluted_1_Q3_USD":0.27,"NetIncomeLoss_3_Q3_USD":31320000.0,"NetIncomeLoss_1_Q3_USD":10287000.0,"StockholdersEquity_0_Q3_USD":451530000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":38534000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":38371000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":37829000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":38059000.0,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-Q","period":"20170228","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170331"}]